Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy대한소화기학회지, 2022, v.79 no.6, 252-259
[학술지논문] Blood Circulating Tumor DNA-based Genomic Profiling and Serial Analysis in Patients With Advanced Biliary Tract Cancer
ANTICANCER RESEARCH, 2025, v.45
no.4
, 1447-1463
SCIE
[학술지논문] Comparison of Survival Outcomes and Toxicities Between Volumetric-modulated Arc Therapy and Conventional Radiotherapy in Early Glottic Cancer
IN VIVO, 2025, v.39
no.6
, 3529-3538
SCIE
[학술지논문] Correlations of biochemical and clinical outcomes with 10-year results after robotic stereotactic body radiotherapy for localized prostate cancer
RADIATION ONCOLOGY, 2025, v.20
no.1
, 157-157
SCIE
[학술지논문] Impact of Thyroid Dose on Radiation-induced Hypothyroidism in Early Glottic Cancer Patients Undergoing Volumetric Modulated Arc Therapy
IN VIVO, 2025, v.39
no.4
, 2397-2404
SCIE
[학술지논문] Improving segmentation precision in prostate cancer adaptive radiation therapy with a patient-specific network
PLOS ONE, 2025, v.20
no.9
, 0332603-0332603
SCIE
[학술지논문] Long-Term Outcome of a Multicenter Prospective Study on Efficacy and Safety of High-Dose Stereotactic Body Radiation Therapy ≥48-h Interfraction Interval for ≤5 cm Hepatocellular Carcinoma
LIVER CANCER, 2024, v.14
no.3
, 248-259
SCIE
[학술지논문] Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814)
CANCER RESEARCH AND TREATMENT, 2024, v.56
no.1
, 272-279
SCIE
[학술지논문] Association Between Thyroid Radiation Dose and Hypothyroidism in Breast Cancer Patients Undergoing Volumetric Modulated Arc Therapy for Regional Nodal Irradiation
IN VIVO, 2023, v.37
no.5
, 2340-2346
SCIE
[학술지논문] Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06)
EJSO, 2023, v.49
no.3
, 589-596
SCIE
[학술지논문] Patterns of locoregional recurrences and suggestion of the clinical target volume in resected perihilar extrahepatic cholangiocarcinoma
Clinical and Translational Radiation Oncology, 2023, v.41
no.100646
, 1-5
SCIE
[학술지논문] Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2022, v.79
no.6
, 252-259
Scopus
[학술지논문] Patterns of Regional Failure after Pancreaticoduodenectomy in Patients with Distal Extrahepatic Cholangiocarcinoma: Suggestion of the Clinical Target Volume for Elective Nodal Irradiation
CLINICAL ONCOLOGY, 2022, v.34
no.1
, 45-51
SCIE
[학술지논문] Role of Adjuvant Treatment in High-risk Patients Following Resection for Gallbladder Cancer
IN VIVO, 2022, v.36
no.2
, 961-968
SCIE
[학술지논문] Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer
PLOS ONE, 2022, v.17
no.9
, 1-11
SCIE
[학술지논문] Neutrophil-to-Lymphocyte Ratio After Definitive Concurrent Chemoradiotherapy Predicts Survival in Patients With Esophageal Squamous Cell Carcinoma.
IN VIVO, 2021, v.35
no.2
, 1133-1139
SCIE
[학술지논문] Optimizing External Beam Radiotherapy as per the Risk Group of Localized Prostate Cancer: A Nationwide Multi-Institutional Study (KROG 18-15)
CANCERS, 2021, v.13
no.11
, 1-16
SCIE
[학술지논문] Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14)
EUROPEAN JOURNAL OF CANCER, 2021, v.157
no.0
, 31-39
SCIE
[학술지논문] A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy.
CANCER, 2020, v.126
no.2
, 363-372
SCIE
[학술지논문] Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
ANTICANCER RESEARCH, 2020, v.40
no.3
, 1771-1778
SCIE
[학술발표] Dosimetric benefits of CT-based online adaptive radiotherapy in stereotactic body radiation therapy for prostate cancer16th European Multidisciplinary Congress on Urological Cancers, 포르투갈, 2024-11-07
European Urology Open Science, 2024
[학술발표] Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancerKSMO2024, 대한민국, 2024-09-26
., 2024